Navigation Links
ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
Date:12/9/2009

SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences On-line Forum on December 15, 2009 at 9:30 a.m. Eastern time.

Interested parties can access a live audio webcast with slide presentation at www.informedinvestors.com, a link to which is available on the ADVENTRX Pharmaceuticals Web site at www.adventrx.com. An archived presentation will be available for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the performance of existing cancer treatments by addressing limitations associated principally with their safety and use. More information can be found on the Company's web site at www.adventrx.com.

SOURCE ADVENTRX Pharmaceuticals, Inc.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
2. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
3. ADVENTRX Pharmaceuticals Announces Closing of Financing
4. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
5. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
6. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
7. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
10. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
11. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... Hamlin Dental Group, multi-location dental office in North Hollywood , Van ... safe and effective options, and can be used alone or in conjunction with other ... care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as well, ...
(Date:3/29/2017)... ... , ... VisualSP has helped over 1.5 million SharePoint users learn the content ... of its Help System for SharePoint was at the farm level. Enterprises using SharePoint ... , The company recently released a modified version of the Help System, VisualSP ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... team. Ruel Williamson brings his extensive knowledge of appraisals, property values, ad valorem ... the real estate valuation industry for more than 40 years. , “Ruel is ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
Breaking Medicine News(10 mins):